EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Monocyte IL-1β predicts adverse cardiovascular events and associates with coronary microvascular dysfunction in kidney transplant recipients

Zhengwei Yin, Qingyan Yang, Jianle Han, Junwei Yang, Tao Li, Jingjun Suo, Shuaiping Yang, Xiaobo Wang, Shuailin Zhao, Chang'an Wang

Frontiers in Cardiovascular Medicine · 07.01.2026 · 12

DOI: 10.3389/fcvm.2025.1689566 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 07.01.2026. Verfasst von Zhengwei Yin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Kidney Transplantation and Nephrology Treatment Center, The Seventh People's Hospital of Zhengzhou, Zhengzhou, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Cardiovascular disease remains the leading cause of death after kidney transplantation. Coronary microvascular dysfunction (CMD) is common in kidney transplant recipients (KTRs), prognostically informative for cardiovascular events, and tightly related to inflammation. We aimed to test whether pretransplant monocytic expression of pyroptosis-related genes ( IL-1β , GSDMD , Caspase-1 , and NLRP3 ) independently predicts long-term mortality and major adverse cardiovascular events (MACE) in KTRs, and to evaluate its associations with CMD.

Methods

We enrolled 305 KTRs. Monocytes were isolated preoperatively and qPCR quantified the four genes (normalized to GAPDH). MACE included death, myocardial infarction, stroke, and heart failure. Multivariable Cox regression was used to adjust for confounders associated with prognosis. CMD was evaluated using coronary flow reserve (CFR) in 41 KTRs and serum syndecan-1 levels (an endothelial injury marker) in 88 KTRs.

Results

Over a median 4.0 years, 62/305 (20.3%) had MACE. IL-1β expression was higher in those with events. In Cox models with IL-1β entered as a standardized continuous variable (per SD), IL-1β independently predicted death (adjusted HR 1.530, 95%CI 1.165–2.009) and MACE (adjusted HR 1.622, 95%CI 1.283–2.052). When modeled categorically as tertiles, the highest vs. lowest IL-1β tertile conferred greater risk (death, adjusted HR 3.771, 95%CI 1.516–9.384; MACE, adjusted HR 4.398, 95%CI 2.003–9.654). IL-1β correlated inversely with CFR (R = −0.40, P = 0.009) and positively with syndecan-1 (R = 0.47, P < 0.001). Other genes showed weaker or nonsignificant associations.

Conclusion

IL-1β is a robust, independent predictor of death and MACE in KTRs. Its associations with impaired CFR and elevated syndecan-1 support a mechanistic link to CMD.

Schlagwörter

Stichwörter der Autor:innen

coronary microvascular dysfunctioninterleukin 1βkidney transplant recipientprognosispyroptosis

Autor:innen und Institutionen

  • Kidney Transplantation and Nephrology Treatment Center, The Seventh People's Hospital of Zhengzhou, Zhengzhou, China.

Zitieren

APA

Yin, Z., Yang, Q., Han, J., Yang, J., Li, T., Suo, J., Yang, S., Wang, X., Zhao, S., & Wang, C. (2026). Monocyte IL-1β predicts adverse cardiovascular events and associates with coronary microvascular dysfunction in kidney transplant recipients. Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1689566

Vancouver

Yin Z, Yang Q, Han J, Yang J, Li T, Suo J, et al. Monocyte IL-1β predicts adverse cardiovascular events and associates with coronary microvascular dysfunction in kidney transplant recipients. Frontiers in Cardiovascular Medicine. 2026;12. doi:10.3389/fcvm.2025.1689566

BibTeX
@article{Yin2026,
  author = {Yin, Zhengwei and Yang, Qingyan and Han, Jianle and Yang, Junwei and Li, Tao and Suo, Jingjun and Yang, Shuaiping and Wang, Xiaobo and Zhao, Shuailin and Wang, Chang'an},
  title = {Monocyte IL-1β predicts adverse cardiovascular events and associates with coronary microvascular dysfunction in kidney transplant recipients},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {12},
  doi = {10.3389/fcvm.2025.1689566}
}
Kostenlos starten →